openPR Logo
Press release

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2024 - By Demand, Report, Share, Analysis, Forecast To 2033

03-11-2024 10:34 AM CET | IT, New Media & Software

Press release from: The Business research company

Artificial Intelligence (AI) In Drug Discovery Market

Artificial Intelligence (AI) In Drug Discovery Market

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Artificial Intelligence (AI) In Drug Discovery Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The artificial intelligence (ai) in drug discovery market size has grown exponentially in recent years. It will grow from $1.37 billion in 2023 to $1.79 billion in 2024 at a compound annual growth rate (CAGR) of 30.8%. The growth in the historic period can be attributed to growth in emerging markets, the rising prevalence of chronic diseases, the increased adoption of artificial intelligence (ai) for cost efficient drug discovery and the increasing strict quality regulations for drug manufacturers.

The artificial intelligence (ai) in drug discovery market size is expected to see exponential growth in the next few years. It will grow to $4.71 billion in 2028 at a compound annual growth rate (CAGR) of 27.4%. The growth in the forecast period can be attributed to the government support, the increasing healthcare expenditure and rising adoption of cloud-based applications and services. Major trends in the forecast period include integration of multi-omics data, use of ai in target selection, use of ai in drug screening, introduction of ai innovation labs, increasing investments and partnerships and collaborations.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

Market Segmentation:
The artificial intelligence (ai) in drug discovery market covered in this report is segmented -
1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning
2) By Drug Type: Small Molecules, Large Molecules
3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics
4) By End User: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users

Major Driver - AI In Drug Discovery Surges With Growing Demand For Personalized Medicine
The growing demand for personalized medicine is expected to propel the growth of the artificial intelligence (AI) in drug discovery market going forward. Personalized medicine refers to a type of medication that prevents, detects, or treats disease using knowledge about a person's own genes or proteins. AI can play a crucial role in the development of personalized medicines at all relevant phases of clinical development and implementation of new personalized health products by finding appropriate intervention targets and testing intervention targets for their utility. For instance, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the US Food and Drug Administration (FDA) approved 12 personalized medicines, which accounted for approximately 34% of all newly approved therapeutic molecular entities. Thus, the growing demand for personalized medicine is driving the growth of the artificial intelligence (AI) in drug discovery market.

Competitive Landscape:
Major companies operating in the artificial intelligence (ai) in drug discovery market report are IBM Corporation, Microsoft Corporation, NVIDIA Corporation, Exscientia, Alphabet, Atomwise Inc., Insilico Medicine, Owkin Inc, Xtalpi Inc, Cloud Pharmaceuticals, Shanghai PharmaceuticS, Standigm, Indegene, Intuition Systems, Innoplexus, Takeda Pharmaceutical Company Ltd., RxPrism, Otsuka Pharmaceutical Co. Ltd., China National Pharmaceutical Group Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharma, Tricog Health Services Pvt. Ltd., Alliance Pharm Pte Ltd., GSK Australia , CytoReason, IIPharma, StoneWise, Adagene, GT Apeiron Therapeutics, Xbiome, Accutar Biotech, DeepMind, Renalytix AI, Iktos, Ipsen Pharma, Galderma S.A., BenevolentAI, Deepflare, Novartis, Gero, Ardigen, Botkin, Care Mentor AI , Diagnocat, GNS Healthcare, Merck & Co., Apotex, Pfizer, Gilead Sciences, Roche, Bayer, AbbVie Inc., GlaxoSmithKline, AstraZeneca, Amgen, Sanofi Pasteur, Abbott Laboratories, Janssen Pharmaceutica, Teva Canada, Accord Healthcare Inc, Acerus Pharmaceuticals Corporation, AA Pharma Inc, Sanfer, Siegfried Rhein, Atomwise, Inc., Bioage, NuMedii, Envisagenics, Aria Pharmaceuticals, Verge Genomics, Berg LLC, Deep Genomics, Cyclica , IQVIA, Quris, GE Healthcare, Avanade , Group42 Holding Ltd, Ilara Health, Adcock Ingram , Johnson & Johnson, Eurolab , Ranbaxy (SA) (Pty) Ltd, Aspen, Rology, hearX Group, DilenyTech

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Top Trend - Strategic Collaborations Propel AI Drug Discovery
Major companies operating in the AI drug delivery market are adopting strategic collaborations to research and discover drugs using AI and are gaining significant popularity in the artificial intelligence in drug discovery market. For instance, in August 2022, Atomwise, a US-based artificial intelligence systems company, partnered with Sanofi. The partnership aimed at computationally identifying and investigating up to five pharmacological targets using the Atomwise AI-powered AtomNet technology. To find, create, and advance lead compounds for up to five Sanofi-exclusive targets, Atomwise received a $20 million upfront payment from Sanofi. Sanofi is a French pharmaceutical and healthcare company.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Artificial Intelligence (AI) In Drug Discovery Market Characteristics
3. Artificial Intelligence (AI) In Drug Discovery Market Trends And Strategies
4. Artificial Intelligence (AI) In Drug Discovery Market - Macro Economic Scenario
5. Artificial Intelligence (AI) In Drug Discovery Market Size And Growth
…..
27. Artificial Intelligence (AI) In Drug Discovery Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model"

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Intelligence (AI) In Drug Discovery Global Market Report 2024 - By Demand, Report, Share, Analysis, Forecast To 2033 here

News-ID: 3421885 • Views:

More Releases from The Business research company

Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. How Will the Foam Tape Market Grow by 2025 in Terms of Size and Growth? In recent times, there has been significant growth in the market size for foam tape. It is projected to escalate from $10.02 billion in 2024 to $10.77 billion in 2025, demonstrating a compound annual growth rate (CAGR)
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 Billion in 2029
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Projected CAGR for the Continuous Positive Airway Pressure (CPAP) Mask Market from 2024 to 2025? In recent times, the market size of the continuous positive airway pressure (cpap) mask has seen robust growth. The market is projected to rise from $2.83 billion in 2024 to $3 billion in 2025,
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis Report
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis R …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Alkyd Coating Market Outlook: How is the Market Expected to Grow by 2025? The market size of alkyd coatings has experienced significant growth in the past few years. The market is projected to expand from $25.13 billion in 2024 to $26.74 billion in 2025, exhibiting a compound annual growth rate
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. Water Free Skincare Market Value Projection: How Much Will the Market Size by 2025? The market size of waterless skincare has experienced a robust increase in recent years. The expected growth is from $15.96 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.

All 5 Releases


More Releases for Pharm

Fenbendazole Market Size, Share and Forecast By Key Players-Jin Dun Pharm, Shand …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Fenbendazole market is anticipated to grow at a compound annual growth rate (CAGR) of 16.05% between 2024 and 2031. The market is expected to grow to USD 68 Billion by 2024. The valuation is expected to reach USD 192.77 Billion by 2031. The fenbendazole market is experiencing notable growth due to increasing awareness of parasitic infections in both
Revolutionizing Revenue: Dexlansoprazole Sustained Release Capsule Market Trends …
Worldwide Market Reports announces the publication of its most recently generated research report titled, "Dexlansoprazole Sustained Release Capsule Market - Forecast to 2030", which offers a holistic view of the Dexlansoprazole Sustained Release Capsule market through systematic segmentation that covers every aspect of the target market. Dexlansoprazole Sustained Release Capsule with 100+ market data Tables, Pie Chat, Graphs, and Figures spread through Pages and easy-to-understand detailed analysis. The information is
Paromomycin Sulfate Market 2030 by Top 10+ Players Pfizer,, Changrui Pharm,, ERF …
Paromomycin Sulfate is an antibiotic used to treat infections caused by certain parasites. It is commonly used to treat visceral leishmaniasis, a serious parasitic disease that affects the internal organs. The market for Paromomycin Sulfate is relatively small compared to other antibiotics, as it is primarily used to treat a specific type of parasitic infection. However, the market for Paromomycin Sulfate is expected to grow as the incidence of visceral
Fosfomycin Market to Witness Huge Growth by 2026 | Northeast Pharm, Ercros, Shin …
The Latest Released Fosfomycin market study has evaluated the future growth potential of Global Fosfomycin market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities
Clopidol Market updates, demand analysis, and expected growth forecast 2021-2027 …
Global “Clopidol” Market Size, Status, and Forecast 2021-2027. In-depth research accumulated to offer Latest insights about acute features of the global Clopidol market. This report provides a detailed overview of key factors in the Clopidol Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. The effect of the COVID-19 outbreak at the enterprise turned into completely assessed. Fully chance evaluation and enterprise recommendations
Paromomycin Market updates, demand analysis, and expected growth forecast 2021-2 …
The new study on the Global “Paromomycin Market” 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the Paromomycin industry. Because of the in-depth overview of the Global Paromomycin market, the recent papers allow investors, traders, and manufacturers to plan some innovative techniques, and meanwhile, align them with operational and commercial enterprise models. Additionally, the Paromomycin market report offers crucial facets at the